Anti-CTLA-4 immunotherapy does not deplete FOXP3+...

Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers

Sharma, Anu, Subudhi, Sumit K, Blando, Jorge, Scutti, Jorge, Vence, Luis, Wargo, Jennifer A., Allison, James P., Ribas, Antoni, Sharma, Padmanee
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-0762
Date:
July, 2018
File:
PDF, 863 KB
english, 2018
Conversion to is in progress
Conversion to is failed